Arecor Therapeutics PLC CEO Sarah Howell provided an update on the company’s progress for the first half of the year. She also provided updates on the specialty pharmaceutical business Tetris Pharma, particularly their glucagon pen Ogluo, for severe hypoglycemia, which is showing market growth in the UK and Germany.
#ProactiveInvestors #ArecorTherapeutics, #Pharmaceuticals, #Biotech, #Glucagon, #StockManagement, #UKMarket, #GermanyMarket, #HealthTech, #EmergencyUse, #Fundraising, #MedicalProducts, #MarketExpansion, #Healthcare, #CEOUpdate, #Biotechnology, #MedicalStock, #UKHealthcare, #GermanHealthcare, #BiotechInvestment, #MedicalInnovation #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews